Myriad Genetics
E133679
Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Myriad Genetics canonical | 1 |
| Myriad Genetics, Inc. | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1169339 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Myriad Genetics Context triple: [Walter Gilbert, coFounderOf, Myriad Genetics]
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
C.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
D.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
-
E.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Myriad Genetics Target entity description: Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
C.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
D.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
-
E.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ |
| businessModel | commercial genetic testing services ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| fieldOfWork |
genomics
ⓘ
molecular diagnostics ⓘ oncology diagnostics ⓘ personalized medicine ⓘ |
| focusesOn |
prognostic testing in oncology
ⓘ
risk assessment for inherited diseases ⓘ treatment selection using genetic information ⓘ |
| foundedBy |
John Huntsman Sr.
ⓘ
Mark Skolnick ⓘ Per Peterson ⓘ Peter Meldrum ⓘ Walter Gilbert ⓘ |
| hasLaboratory |
CAP-accredited laboratory
ⓘ
CLIA-certified laboratory ⓘ |
| hasResearchFocus |
DNA sequencing
ⓘ
biomarker discovery ⓘ companion diagnostics for targeted therapies ⓘ hereditary breast cancer ⓘ hereditary colorectal cancer ⓘ hereditary ovarian cancer ⓘ hereditary prostate cancer ⓘ |
| headquartersLocation |
Salt Lake City
ⓘ
surface form:
Salt Lake City, Utah, United States
|
| inception | 1991 ⓘ |
| industry |
biotechnology
ⓘ
genetic testing ⓘ |
| involvedIn | U.S. Supreme Court decision on gene patents ⓘ |
| legalCase | Association for Molecular Pathology v. Myriad Genetics, Inc. ⓘ |
| legalIssue | patentability of human genes ⓘ |
| listedOn | NASDAQ ⓘ |
| notableFor |
BRCA1 and BRCA2 genetic testing
ⓘ
development of genetic tests for inherited cancer risk ⓘ |
| offersTo |
clinical laboratories
ⓘ
healthcare providers ⓘ patients through physician orders ⓘ |
| productOrService |
companion diagnostic tests
ⓘ
hereditary cancer risk tests ⓘ pharmacogenomic tests ⓘ prenatal genetic tests ⓘ psychiatric pharmacogenetic tests ⓘ |
| regulatoryBody |
Centers for Medicare & Medicaid Services
ⓘ
Food and Drug Administration ⓘ
surface form:
U.S. Food and Drug Administration
|
| tickerSymbol | MYGN ⓘ |
| usesTechnology |
Sanger sequencing
ⓘ
bioinformatics analysis of genomic data ⓘ next-generation sequencing ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Myriad Genetics Description of subject: Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Myriad Genetics, Inc.